Antioxidants: New Kid On The Block For Pain Relief?

November 7, 2006

Antioxidant-based pain killers may one day become a viable alternative to addictive medications such as morphine. Researchers found that synthetic antioxidants practically eradicated pain-like behavior in nearly three-quarters of mice with inflamed hind paws.

“When it comes to pain killers, there aren't many choices between over-the-counter pain relievers like ibuprofen and aspirin and prescription opiates like morphine,” said Robert Stephens, a professor of physiology and cell biology at Ohio State University. He's the lead author of a study examining the effects of antioxidants as pain killers.

“We need drugs that fall somewhere between these two extremes,” Stephens said. “Someone suffering from chronic pain can become dependent on, or even addicted to, heavy-duty pain killers like morphine.”

The study appears in a recent issue of the journal Behavioural Brain Research.

Chronic pain is such a formidable problem that, in 2000, Congress passed a bill designating January 1, 2001 as the beginning of the “Decade of Pain Control and Research.”

Antioxidants neutralize free radicals, substances that damage cells. While our bodies constantly produce free radicals, healthy tissues inactivate these damaging substances and keep their levels in check. It's when free-radical production somehow exceeds the body's natural defenses that problems occur. Researchers have linked this excessive production to diseases like cancer and Alzheimer's.

A handful of studies published in the last 10 years suggest that free radicals may also contribute to chronic pain. Left unchecked, free radicals build up in the body and can further damage already-injured tissue.

An equally small number of studies, including those by Stephens, suggest that antioxidants may fight chronic pain by helping the body to break down free radicals.

“Studying the pain-killing effects of antioxidants is an emerging area of research,” Stephens said. “The FDA hasn't approved antioxidants for the treatment of chronic pain. But down the road we may see some drugs that contain antioxidants.”

Stephens and his colleagues first injected one of three different synthetic antioxidants into mice. An additional group of control mice received only saline. The antioxidants used in this study – PBN (phenyl-N-tert-butylnitrone), TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxy) and NAC (N-acetyl-L-cysteine) – aren't the same as those found in fruits and vegetables, and two, PBM and TEMPOL, are currently only available for scientific purposes. NAC is available as a dietary supplement.

“Right now we're trying to show that antioxidants are viable pain killers,” Stephens said. “Similar work by other researchers suggested that these antioxidants were the best available. And while certain foods likely contain pain-killing antioxidants, these agents have not been systematically tested as pain relievers.”

Shortly after the antioxidant or saline injections, the researchers injected formalin, an irritant, into the left hind paw of each mouse. Formalin causes inflammation, which provokes pain-like behavior in mice. Researchers then spent the next 30 minutes studying how much time an animal spent licking and biting its injured paw. This kind of behavior suggests that the animal is in pain or discomfort.

The researchers divided the 30-minute observation session into three distinct periods – a five-minute acute phase, when the body first senses and reacts to pain, followed by a 5- to 15-minute period of relative stillness, as the body uses its own mechanisms to try to inhibit the pain, and ending with a 15- to 30-minute period called the tonic phase, during which a mouse starts to again vigorously lick or bite its irritated paw, suggesting that it still feels pain or discomfort.

The three antioxidants significantly reduced the amount of time that mice spent biting and licking their injured paw during both the acute and tonic phases. The researchers reported a 70- to 90-percent reduction in pain-related behaviors during the acute phase, and a 78- to 98-percent reduction in such behavior during the tonic phase.

“We were surprised to see such a major decrease in pain in the mice, particularly during the acute phase,” Stephens said. “The antioxidants seem to preempt pain-like behavior.

“Other investigators have given antioxidants to rodents after experimentally inducing pain and have found that the drugs relieve pain to a similar extent.”

Stephens conducted the study with researchers from Ohio State and from Ataturk University in Erzurum, Turkey.

Source: Ohio State University


   
Rate this story - 4.1 /5 (11 votes)


November 7, 2006 all stories

Comments: 0

4.1 /5 (11 votes)

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Whooping cough vaccine may be losing its punch: study

Medicine & Health / Diseases

created 49 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found. A team of Australian scientists has ...


IQ among strongest predictors of cardiovascular disease -- second only to cigarette smoking

Medicine & Health / Health

created 3 hours ago | popularity not rated yet | comments 6 | with audio podcast

as reflected by low results on written or oral tests of IQ - have been associated with a raised risk of cardiovascular disease, no study has so far compared the relative strength of this association with other established ...


Communication breakdown: What happens to nerve cells in Parkinson's disease

Medicine & Health / Neuroscience

created 3 hours ago | popularity not rated yet | comments 0 | with audio podcast

A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate. ...


A common cholesterol drug fights cataracts, too

Medicine & Health / Medications

created 2 hours ago | popularity not rated yet | comments 1

Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men ...


Changes proposed in how psychiatrists diagnose

Medicine & Health / Psychology & Psychiatry

created 2 hours ago | popularity not rated yet | comments 0

(AP) -- Don't say "mental retardation" - the new term is "intellectual disability." No more diagnoses of Asperger's syndrome - call it a mild version of autism instead. And while "behavioral addictions" will be new to doctors' ...